MountainView Hospital welcomes Dr. Aaron Goodman
MountainView Hospital is proud to announce the addition of Aaron Goodman, MD, to its medical staff. Dr. Goodman is a board-certified hematologist and medical oncologist who brings extensive experience in the diagnosis and treatment of blood disorders and cancers. His arrival strengthens MountainView Hospital’s commitment to providing advanced, compassionate cancer care to the Las Vegas community.
Dr. Goodman joins MountainView Hospital from UC San Diego Health, where he served as a Professor of Medicine and was widely recognized for his clinical expertise and research in hematologic malignancies. He has authored numerous publications and served as a principal investigator in national clinical trials, contributing to advancements in therapies for lymphoma, leukemia and bone marrow disorders.
“We are honored to welcome Dr. Goodman to MountainView Hospital,” said Mitch Geiger, interim chief executive officer, MountainView Hospital. “His exceptional clinical background, leadership in research and dedication to patient-centered care align perfectly with our mission to deliver top-quality cancer care close to home.”
Dr. Goodman is accepting new patients at MountainView Hospital, where he will continue to focus on individualized treatment approaches and innovative therapies for patients with complex hematologic and oncologic conditions.
“I’m thrilled to join MountainView Hospital and serve the Las Vegas community,” said Dr. Goodman. “This is an exciting opportunity to expand access to comprehensive cancer care while continuing to advance the science and compassion that define modern oncology.”
Dr. Goodman earned his medical degree from Emory University School of Medicine in Atlanta, GA, followed by a residency at Washington University School of Medicine in St. Louis, MO where he was first introduced to the lifechanging nature of bone marrow transplantation.
The Sarah Cannon Transplant and Cellular Therapy Program at MountainView Hospital includes an inpatient unit, outpatient infusion center and Day Hospital. The program is the only program in the state of Nevada and has received internationally-recognized accreditation by the Foundation for Accreditation of Cellular Therapy (FACT) for adult autologous transplantation and immune effector cell therapy (IECT).
As part of the Sarah Cannon Therapy Network, programs are brought together through physician-led blood cancer programs across the United States and United Kingdom and is one of the largest providers of transplant and cellular therapies in the world.
The Sarah Cannon Transplant & Cellular Therapy Program at MountainView Hospital includes an inpatient unit and outpatient clinic. As part of the Sarah Cannon Transplant & Cellular Therapy Network, programs are brought together through physician-led blood cancer programs across the United States and United Kingdom and is one of the largest providers of transplant and cellular therapies in the world.
The Sarah Cannon Transplant & Cellular Therapy Program at MountainView Hospital is part of the Sarah Cannon Transplant & Cellular Therapy Network, offering patients convenient, community-based access to complex blood cancer care including acute leukemia, blood and marrow transplantation, clinical trials and innovative therapies. The Network treats approximately 1,600 transplant and cellular therapy patients annually across its nine FACT/JACIE accredited programs in the United States and United Kingdom.